USTR Preps More Drugs For Duty-Free Treatment

Law360, New York (June 2, 2010, 6:33 PM EDT) -- Gearing up to add hundreds more drugs to the 7,000 currently enjoying tariff exemptions under the pharmaceutical zero-for-zero initiative, the Office of the U.S. Trade Representative has asked the International Trade Commission to vet the suggested additions.

Embarking on the fourth review of the trade initiative, U.S. Trade Representative Ron Kirk sent a letter to ITC Chairwoman Shara Aranoff on May 27 seeking the commission's advice on the several hundred drugs and chemical components being proposed for duty-free treatment.

From abagovomab to zotarolimus, approximately 400 hundred...
To view the full article, register now.